`

SYNAPS Dx

Biotechnology

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About SYNAPS Dx

What does Synaps dx do?+

Synaps Dx has the only minimally invasive highly accurate test, DISCERNTM, for Alzheimers Disease. Multidisciplinary teams at the NIH and the Rockefeller Neurosciences Institute, led by Dr. Alkon, over the last 30 years led to the development of the three biomarkers. The three biomarkers comprise an AD-Index assay, a Morphometric Imaging assay, and a PKC Epsilon assay. FDA has granted SDx Breakthrough Status. Our diagnostic biomarkers have been confirmed by autopsy validation (NIH Gold Standard)

What is Synaps dx's industry? +

Synaps dx operates in the Biotechnology industry.

What is Synaps dx's revenue? +

Synaps dx's revenue is 11m - 100m

What is Synaps dx's company size? +

Synaps dx has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.